A team of researchers from the University of Oxford has shown for the first time that it is possible to track the progression of Parkinson\u2019s Disease accurately using specially trained machine learning algorithms to analyse data derived from sensor devices worn by patients.
Our researchers have shown the potential of a new gene therapy approach to silence human sensory neurons as a means of treating persistent pain. Many current drugs for chronic pain are highly addictive, which makes it important to discover new alternatives.
PAINCAST: Neuropathic Pain Unravelled, a creative podcast about living with long-term pain, is part of a ground-breaking four-year collaborative research project into neuropathic pain.
In the midst of a global opioid epidemic, a team of scientists is exploring natural killer (NK) cells as an alternative treatment for neuropathic pain.
The Davies and Rinaldi laboratories led 'glitter-essence imaging', a craft-based engagement activity at Freeland Primary School Science Day on 17 March 2023 for Brain Awareness Week.
A ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease (MND, also known as ALS), is announced today on Global MND Awareness Day.
The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease
NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient\u2019s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.
Establishing preclinical models of Alzheimer\u2019s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer\u2019s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.
Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).
![\"A](\"https://www.ndcn.ox.ac.uk/news/wearable-sensors-provide-early-detection-of-progression-in-parkinsons-disease/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n